This exploration was completed to evaluate the opportunity of the CPPs with tumor-concentrating on Homes to provide a cytotoxic payload to HCC cells. We explored using a CXCR4-concentrating on peptide, T22, fused with cytotoxic peptide PE24, being a novel therapeutic system for CXCR4+ HCC cells. T22 was preferred since the nanocarrier as a conseque